Citation Impact
Citing Papers
Risk Factors for Venous Thromboembolism
2003 Standout
The relationship between prognostic and predictive factors in the management of breast cancer
1998
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer
1994
Two-Color, Cytokeratin-Labeled DNA Flow Cytometric Analysis of 332 Breast Cancers
2001
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study.
1994
Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma
1999 Standout
Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.
1996
Prognosis of Cancers Associated with Venous Thromboembolism
2000 Standout
Adjuvant Therapy of Premenopausal and Menopausal High-Risk Breast Cancer Patients: Present status of the Danish Breast Cancer Cooperative Group Trials 77-B and 82-B
1988
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Quality of Life in Long-Term, Disease-Free Survivors of Breast Cancer: a Follow-up Study
2002 Standout
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
1995 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer
2002 Standout
Hormone receptors in malignancy
1992
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Prevention of Venous Thromboembolism
2004 Standout
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Management and prevention of thromboembolic events in patients with cancer-related hypercoagulable states
1993
Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.
1990
Hemostatic alterations in cancer patients
1992
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Cancer and venous thromboembolism
1996
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
2010 Standout
Breast cancer adjuvant therapy
1990
Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy
1997 Standout
Prevention of Venous Thromboembolism
2008 Standout
Multiple-Treatments Meta-analysis of Chemotherapy and Targeted Therapies in Advanced Breast Cancer
2008
Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism
2000 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation.
1995
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2004 Standout
Lymphatic Mapping and Sentinel Node Biopsy in the Patient With Breast Cancer
1996 Standout
Maturation of the hemostatic system during childhood
1992 Standout
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.
2000
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
2002 Standout
Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia
1997 Standout
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
2005 Standout
State-of the-Art Review : Prevention of Thrombosis in Gynecologic Malignancy
1998
Venous Thromboembolism and Cancer: Risks and Outcomes
2003
Clinical decision-making in early breast cancer.
1993
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
1992 Standout
Activation of blood coagulation in cancer: Trousseau's syndrome revisited
1983
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
Chemotherapy of carcinoma of the cervix
1977
The Hypercoagulable States
1985
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
COAGULATION DISORDERS IN CANCER
1996
Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen
1984
Low-molecular-weight heparin in the management of Tyrousseau's syndrome
1997
Vascular toxicity associated with antineoplastic agents.
1986
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
Applications of nanotechnology in drug delivery systems for the treatment of cancer and diabetes
2006
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
2006 Standout
Understanding the Utility of Adjuvant Systemic Therapy for Primary Breast Cancer
2001
Tumors: Wounds That Do Not Heal
1986 Standout
The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta‐analysis, and clinical practice guideline: a systematic review
2015 Standout
Works of Tormey Dc being referenced
Clinical evaluation of hexamethylmelamine (NSC-13875).
1973
Mitomycin and tamoxifen versus mitolactol, doxorubicin, and tamoxifen in patients with previously treated breast cancer.
1985
Chemotherapy versus observation in high-risk node-negative breast cancer patients.
1992
Adriamycin plus vincristine alone or with dibromodulcitol or ICRF-159 in metastatic breast cancer.
1981
Venous thrombosis during multimodal treatment of primary breast carcinoma.
1981
Prognostic potential of DNA flow cytometry measurements in node-negative breast cancer patients: preliminary analysis of an intergroup study (INT 0076).
1992
Postoperative chemotherapy and chemohormonal therapy in women with node-positive breast cancer.
1986